Therapeutic algorithm for Patients with severe Hypercholesterolemia or isolated Lipoprotein(a)-Hyperlipoproteinemia with progressive cardiovascular disease: PCSK9-Inhibitors, Lipoprotein Apheresis or both?

Therapeutic algorithm for Patients with severe Hypercholesterolemia or isolated Lipoprotein(a)-Hyperlipoproteinemia with progressive cardiovascular disease: PCSK9-Inhibitors, Lipoprotein Apheresis or both?

Nephrologisches Zentrum GöttingenGbR Priv. Doz. Dr.med. V. Schettler

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht.